TotalMarketCap

Takeda Pharmaceutical

TAKNYSE JapanHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$67.131 B

$21.25 +0.88%

Close of 6 Nov 2026

As of 6 Nov 2026, Takeda Pharmaceutical (TAK) has a market capitalization of $67.1B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #13GSKGSK$101.9B
  2. #14Regeneron PharmaceuticalsREGN$93.4B
  3. #15Takeda PharmaceuticalTAK$67.1B
  4. #16Teva Pharmaceutical IndustriesTEVA$48.7B
  5. #17BeOne MedicinesONC$44.0B

What if Takeda Pharmaceutical were worth as much as…

Open the what-if tool →

Gold $28.2T

$8,936.16

Per share 421× higher

Bitcoin $1.53T

$483.52

Per share 22.8× higher

Apple $5.02T

$1,587.35

Per share 74.7× higher

Or at a round number

$100.0B$200.0B$500.0B$1.00T

Where these numbers come from

Share counts and financials for Takeda Pharmaceutical are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.